Absci Corporation (ABSI) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, and thank you for standing by. Welcome to the Absci Fourth Quarter and Full Year twenty twenty five Business Update Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, we'll open up for questions. To ask a question during the session, you will need to press 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press 11 again. Please be advised that today's call is being recorded. I would now like to hand it over to our first speaker, Alex Khan, Corporate Vice President, Investor Relations. Please go ahead. Thank you. Earlier today, ABSI released financial and operating results for the quarter and full year ended 12/31/2025. If you haven't received this news release or if you'd like to be added to the company's distribution list, please send an email to investorsabsci dot com. An archived webcast of this call will be available for replay on Absci's Investor Relations website at investors.absci.com for at least ninety days after this call. Joining me today are Sean McLean, Absci's Founder and CEO Zach Jonasson, Chief Financial Officer and Chief Business Officer and Rothy Somarotni, Absci's new Chief Medical Officer. Before we begin, I'd like to remind you that management will make statements during this call that are forward looking within the meaning of the federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated and you should not replace undue reliance on forward looking statements. These include statements regarding the development and clinical progress of ABS-two zero one, anticipated clinical trial design, enrollment...